Article
Use of intravitreal steroid injections needs to be fully explored for safety as well as efficacy
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
OKYO Pharma announces positive results from phase 2 trial of urcosimod for neuropathic corneal pain
3 Things You Should Know About Interventional Glaucoma Comanagement
Harrow enters into agreement with Samsung Bioepis for commercial rights to its ophthalmology biosimilar portfolio
Patient-Centered Treatment Strategies in the Management of nAMD and DME
FDA accepts for review Aldeyra Therapeutics’ resubmitted New Drug Application for reproxalap
FDA grants fast track designation to Sanofi’s SAR446597